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LONG TERM MEMODIALYSIS (HD) IN CHILDREN AND 
1510ADOLESCENTS. Valerie Johnson, Robert A. Weiss 
and Ira Greifer, Albert Einstein College of 
Medicine, Dept. of Pediatrics, Bronx, N.Y. 
Despite agreement among pediatric nephrologists that 
renal transplantation is the therapy of choice, succe- 
ssful transplantation is often impossible due to cyto- 
toxic antibodies. Ten pts (mean age at onset HD 10.8 
yrs) have been on maintenance HD for more than 4 yrs 
(mean duration 5.3 yrs). 8 pts. have undergone success- 
ful transplantation with grafts functioning less than 
six months. Vascular access, even in children OK 8 kg, 
has been by fistula exclusively. Mean fistula survival 
in 9 pts has been 59.7 months although a tenth patient 
has required 19 access procedures over 6 yrs. Manifes- 
tations of osteodystrophy such as epiphyseal slipping, 
genu valgum and brown tumors have been observed in 8/ 
10, often due to poor compliance with the medication 
regimen. Linear growth has been poor even when corr- 
ected for skeletal age, despite biochemical control of 
uremia and nutritional counseling. An additional com- 
plication has been hemochromatosis (serum ferritin 
11,000) in one adolescent and elevated serum ferritins 
in seven other pts. Promoting psychosocial maturation 
and rehabilitation through the use of "group therapy" 
sessions have been successful in achieving full school 
attendance and realistic career planning in all pat- 
ients. 
IDIOPATHIC HYPERCALCURIA (IHC) AND GROSS HEMA- 
el511 TURlA (GH) IN CHILDREN. Alok Kalia and Luther B. Travis, 
Univ. of Texas Med. Br., Dept. of Pediatrics, Galveston,Tx. 
Although onset of GH prior to calculus formation has been reported, the 
association of GH and IHC without clinical or radiological evidence of 
nephrolithiasis has not been described. Six children have been identified 
who presented with asymptomatic and recurrent GH in whom no calculus 
could be demonstrated radiographically. Investigations did not reveal 
any renal or urinary tract pathology which could account for the hema- 
turia. ICH was documented in five; the sixth later passed a calcium 
oxalate calculus. Five had a family history of renal calculi. Three con- 
tinued to have recurrent gross and micmscopic hematuria with the initial 
renal calculus developing after 6 months, 5 years and 10 years. Two of 
the others were started on a thiazide diuretic and the sixth on chlor- 
thalidone soon after onset of hematuria and confirmation of IHC. There 
was prompt cessation of hematuria without recurrence after 9, 9 and 
24 months. W e  suggest that measurement of urinary calcium excretion as 
part of the initial evaluation of a child with GH may, in some cases, 
obviate invasive investigations and allow for effective therapy. 
MONONUCLEAR CELL CHEMOTAXIS IN EXPERIMENTAL INTERSTI- 
TIAL NEPHRITIS. Thomas L. Kenned and Martha Merrow, 
university of Connecticut Health bnter, Department of 
Pediatrics, Farmington, Connecticut and Michael E. Norman, The 
Children's Hospital of Philadelphia, Philidelphia. 
Because the inflammatory infiltrate in antitubular basement 
membrane nephritis in guinea pigs (Steblay nephritis) is pre- 
dominantly mononuclear, the stimulus for monocyte and macrophage 
recruitment was studied. The tubulointerstitial inflammation 
begins 10-14 days following injection with heterologous tubular 
basement membrane antigen. Sera were obtained from the renal 
vein in order to avoid the difficulties of systemic inactivation 
or dilution encountered when trying to identify chemotactic 
activity (CA) from peripheral blood. These samples, as well as 
renal homogenates, were compared to renal arterial sera for CA 
using peritoneal mononuclear cells. Sera and homogenates were 
obtained from nephritic and control animals at several times in 
the course of the disease. CA is detected in samples obtained 
from day 7-15 and is maximal at day 10. The CA is heat stable 
and is most prominent in the renal venous serum suggesting an 
origin from the kidney. Use of the sera as a chemoattractant 
for guinea pig polymorphonuclear leukocytes produces no cell 
recruitment and suggests the CA is specific for mononuclear celk 
The alternative pathway of complement has been implicated in the 
pathogenesis of Steblay nephritis and complement derived chemo- 
tactic factors may prove to be responsible for CA. However, 
measurable complement activation reflected in decreased hemolyt- 
&a,a$&gfgt(g~~~?.or in depleti" of complement proteins (C3, 
PERITONITIS IN CHILDHOOD NEPHROTIC SYNDROME. Alan M. 
Krensky, Warren E. Grupe, Julie R. In elfin er. Har- 1513 a d i c a l  school. Department of Peziatrib. Child- 
ren's Hospital Medical Center. Boston, Massachusetts. 
A retrospective review (1970-1980) of 310 children with idio- 
pathic nephrotic syndrome revealed 24 episodes of peritonitis in 
19 patients (6.9 2 3.7 years old). None were on cytotoxic drugs 
and only 64% were on steroids at the onset of peritonitis. All 
had proteinuria; 23 occurred during a relapse and one was at pre- 
sentation of nephrosis. No morphologic subtype was at significant 
-1y greater risk for peritonitis. Abdominal pain, tejnderness, 
edema, ascites, leukocytosis (22,300 f 7,700 wbc/mm ) were uni- 
versal. Other signs and symptoms included: fever (96%), anorexia 
(65%), vomiting (65%), diarrhea (52%J, and abdominal. wall cellu- 
litis (22%); 17/19 had > 1000 wbc/mm of peritoneal fluid. Gram 
stain was positive in only 7/18. Organisms isolated included 
pneumococcus (13), E. coli (5), E. coli and B. fragilis (1-with 
appendicitis), and a-streptococcus (1); 4 were culture negative. 
Only 1/8 pneumococci typed is not included in the commercial vac- 
cine (type 33). All pneumococci and E. coli were sensitive to all 
antibiotics routinely tested. Serum IgG levels in 13 episodes 
measured were dramatically reduced (116277 mg%) compared to 43 
control nephrotics (579+293; p < 0.001). Thus, peritonitis is 
stil.1 common in patients with nephrosis (6%); second episodes are 
frequent (26%); pneumococcus is the most frequent agent (54%) 
with 7/8 types represented in available vaccine. Patients in 
relapse, with ascites, edema, and severe hypogammaglobulinemia 
appear at greatest risk. 
ELEVATION OF NEPHROGENOUS CYCLIC ADENOSINE MONOPHOS- 
PHATE (Neph CAMP) AS EVIDENCE OF EARLY RENAL OSTEODYS- 
Harmon, Julie R. Ingelfinger, John A. Kirkpatrick. Harvard Medi- 
cal School, Children's Hospital Medical Center, Departments of 
Pediatrics and Radiology, Boston, Massachusetts. 
To determine at which point in chronic renal insufficiency 
(CRI) the physiologic conditions for altered bone metabolism ap- 
pear, radiographs, serum chemistries, parathyroid hormone (PTH), 
and neph cAMP were evaluated in 25 children with CRI compared to 
7 children with benign renal disease and normal renal function: 
PATIENT 1 2 g Phos Alk P PTH Ne h cAMP 
GROUP mg/dl mg/dl 3 1  !.IlE9/ml nmo$lOOmlGF 
Normal 7 0.6 9.7 3.9 9 50 1.4 
CRI 10 5.7 8.6 5.3 160 370 5.4 
Hemodialysis 5 9.0 9.5 3.4 94 181 4.6 
Transplant 10 2.4 9.7 4.6 76 155 3.3 
Normal range .3-.95 9-11 3.5-4.5 50-125 20-60 0-4 
Neph cAMP increases linearly with creatinine (Cr) (r=0.81) and 
PTH (r=0.89) except for patients on chronic hemodialysis, in whom 
a metabolic steady state did not exist, or for patients with ser- 
um Cr > 8.0mg/dl. Serum Cr appropriate for age and height was un- 
iversally associated with neph CAMP< 4.0nmo1/100mlGF, while neph 
cAMP was elevated in 9/15 patients with Cr > l.Omg/dl and all 
patients with Cr > 3.5mg/dl. Both PTH and neph CAMP were elevated 
in-asymptomatic patients with Cr as low as 1.45mg/dl. Neph cAMP 
> 4.0nmo1/100mlGF is a reliable, non-invasive measure of early 
changes consistent with the development of renal osteodystrophy 
even before routine changes are evldent. 
Depts. of Ped. Neph. & Med. 
Linear growth failure is a major complication of CRF unique to 
children and is related to renal osteodystrophy (ROD). 19 chil- 
dren, ages 2.8-16.4 yrs with CRF and BH of osteomalacia (OM), os- 
teitis fibrosa (OF) or bdth (OFM) were given 1-2 mcg/kg/d of 25D 
to evaluate effects on ROD & GV. GV was defined by standard de- 
viation scores on Tanner growth charts, the preferred method of 
expressing growth in pts with CRF. Group GV (meanfSEM) was 
-1.75f.45 in the pre-Rx year, increasing to +.2f.31 after the 1st 
Rx yr, and correlated with an increase in serum 250 of 42f8 nglml 
to 244'20 nglml (r=.37, p<.002). Pre-Rx BH showed 7 pts with OM, 
9 with OFM, & 3 with OF. Pre-Rx GV was similar in the 3 groups, 
but increased in OM (p<.002) while remaining unchanged in OFM 
(p=NS) after the 1st Rx year. Data were insufficient to analyze 
OF pts. BH after the 1st Rx year normalized in 4/7 OM, 2/9 OFM, 
and 213 OF. GV remained unchanged (p=NS) after 1st Rx year over 
the subsequent 3 Rx yrs in all BH groups despite 7 pts progress- 
ing to ESRF. Changes in GV & BH did not correlate with C02, P04, 
Ca, iPTH or GFR when pre-Rx levels were compared to 1st or later 
Rx years. In conclusion: 250 often heals abnormal BH, especially 
OM; is associated with an increase in GV after 1st Rx year and 
its preservation in ensuing Rx years. Supported in part by The 
Upjohn Company. 
